ANTIDIABETIC DRUGS PHARM EXAM 3

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/39

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:53 PM on 9/19/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

40 Terms

1
New cards

Oral - insulin secretagogues MOA

stimulate release of insulin

2
New cards

Oral insulin secretagogues classes

sulfonylureas, meglitinides (SSM)

3
New cards

Oral insulin secretagogues - sulfonylureas drugs

glipizide, glybunde, glimepride

4
New cards

Oral insulin secretagogues - sulfonylureas drugs AE

decrease BSL, weight gain

5
New cards

Oral insulin secretagogues - sulfonylureas caution!

pregnancy, renal/hepatic disease

6
New cards

Oral insulin secretagogues - meglitinides

faster acting, always follow with meal

7
New cards

Oral insulin secretagogues - metglitinides drugs

repaglinide, nateglinide

8
New cards

Oral- Thiazolidinedions drugs

piglitazone, rosiglitazone (AZONE)

9
New cards

Oral- Thiazolidinedions AE

edema, URI, sinusitus, HF, weight gain, bone/bladder cancer

10
New cards

Oral- Alpha glucose inhibitors drugs

acarbose, migitol

11
New cards

Oral- alpha-glucose inhibitors AE

limited effectivness, GI disturbances, liver dysfunction

12
New cards

Oral- Biguanides drugs

metformin

13
New cards

Oral- Biguanides MOA

supresses hepatic glucose, increases glucose uptake

14
New cards

Oral- Biguanides AE

lactic acidosis, avoid alcohol, decrease B12

15
New cards

What should you hold with IV dye studies due to renal insufficiency

Oral insulin secretagogues - Biguanides drugs (metformin)

16
New cards

Oral- SGLT2 inhibitor drugs

canagliflozin, dapaliflozin, empagliflozin (FLOZIN)

17
New cards

Oral- SGLT2 inhibitor MOA

secretes sugar from urine

18
New cards

positives of Oral SGLT2 inhibitors

decrease HF risk, cardio and renal protection

19
New cards

Oral- Incretin mimetics categories

oral GLP1, DPP4 inhibitors

20
New cards

Oral- Incretin mimetics (oral GLP1) drugs

semaglutide

21
New cards

Oral- Incretin mimetics (oral GLP1) MOA

slows gastric emptying, increases satiety

22
New cards

Oral- Incretin mimetics (oral GLP1) AE

pancreatic/thyroid cancer, hypoglycemia with insulin

23
New cards

Oral- Incretin mimetics (DPP4) drugs

sitagliptin, saxagliptin, alogliptin, linagliptin (GLIPTIN)

24
New cards

Oral- Incretin mimetics (DPP4) AE

nasal inflammation, URI, pancreatitis, HA

25
New cards

Injectable insulin - ultra short drugs

afreeza, insulin human powder

26
New cards

Injectable insulin - ultra short route of admin

inhaled

27
New cards

Injectable insulin - rapid short drugs

lispro, aspart, gluline

28
New cards

Injectable insulin - rapid short drugs admin route

SQ witih meal

29
New cards

Injectable insulin - short drugs

human insulin

30
New cards

Injectable insulin - intermediate drugs

NPH

31
New cards

Injectable insulin - intermediate drugs route of admin

1-2 x day between meals, clear to cloudy

32
New cards

Injectable insulin - long drugs

degludec

33
New cards

Injectable insulin - ultra long meds

glargine, detemir

34
New cards

Injectable insulin - ultra long med route of admin

SQ once a day

35
New cards

Amylin mimetic target

T1 T2

36
New cards

Amylin mimetic drug

pramlintide

37
New cards

Injectable incretin mimetics target

only T2

38
New cards

Injectable incretin mimetic categories

GLP1 and GLP1/GLP

39
New cards

Injectable incretin mimetic GLP-1 drugs

Irraglutide, semaglutide, dulaglu

40
New cards

Injectable incretin mimetics GLP1/GLP drugs

tirezpatide